VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 361 filers reported holding VANECK VECTORS ETF TR in Q2 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,635,000 | -25.6% | 50,000 | -50.0% | 2.12% | -33.7% |
Q1 2018 | $2,198,000 | -62.2% | 100,000 | -54.5% | 3.20% | -52.3% |
Q3 2016 | $5,815,000 | +19.9% | 220,000 | +25.7% | 6.72% | +41.6% |
Q2 2016 | $4,849,000 | – | 175,000 | – | 4.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |